Bile Acids and Pregnancy
Pregnancy represents an allograft in so far that half of the antigens are foreign to the mother. Therefore, a bidirectional interaction between the maternal and the fetal immune systems must exist, which could be disturbed by preexisting autoimmune liver diseases. Since nowadays autoimmune liver diseases are increasingly detected as early stage diseases due to modern diagnostic procedures, e.g. in women of childbearing age, and since the number of posttransplant pregnancies has become an issue due to improved survival, questions concerning regnancy, autoimmune liver disease and treatment options with bile acids and/or immunosuppressants are of an ever-increasing interest.
This book, the proceedings of a Falk Workshop held in Freiburg, Germany, on June 2, 2002, is certainly unable to give any definite answers to any of the hundreds of still remaining questions in this fascinating field, but hopefully it will help to stimulate and initiate cooperation among immunologists, bile acid researchers, gynaecologists and internists.
Comentarios de usuarios - Escribir una reseña
No hemos encontrado ninguna reseña en los sitios habituales.
Immunology of pregnancy
Intrinsic susceptibility of mouse trophoblasts to NKcellmediated attack in vivo
Induction of immunological tolerance to fetal antigens during pregnancy
The influence of pregnancy on cytokine production
MHC expression in the human placenta and role of HLAG
Ten ways to suppress the maternal immune system
Pregnancy liver disease and bile acids
Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy clinical results
Pregnancy and hepatic transport implications for the pathogenesis of intrahepatic cholestasis of pregnancy
The influence of ursodeoxycholic acid and maternal cholestasis on bile acid transport across the placenta
Effects of highdose UDCA on bile acid metabolism of newborns and mothers with cholestasis of pregnancy
Immune modulation by cholestasis and bile acids
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis and primary sclerosing cholangitis in pregnancy
Ursodeoxycholic acid therapy and progesterone in intrahepatic cholestasis of pregnancy
activity allogeneic alterations amount associated bile acids bile salts blood canalicular CDCA changes cholestasis of pregnancy cholestatic circulation Class clinical compared concentration conjugated cytokines decrease delivery dose downregulation encounter et al explain expression Falk Symposium fetal antigens fetus Figure function gene groups hepatic Hepatobiliary Hepatol Hepatology HLA-G human immune response immune system Immunol immunological immunosuppressive improve increased induced Inflammatory Bowel Diseases inhibition inhibitory effect intrahepatic cholestasis involved ISBN leads levels liver diseases lymphocytes maternal immune maternal T cells mechanisms membrane metabolites mice molecular molecules mother observed occurs organic patients peripheral placenta potential present production progesterone protein pruritus receptor reduced Reference regulation rejection reported response Reyes H role secretion serum shown significant similar specific suggest tests therapy tion tissue tolerance transgenic transport treated treatment trophoblast UDCA umol/L ursodeoxycholic acid values weeks women
Todos los resultados de la Búsqueda de libros »
Cholestatic Liver Diseases: Therapeutic Options and Perspectives: In honour ...
U. Leuschner,U. Broomé,A. Stiehl
No hay ninguna vista previa disponible - 2004